AI주식인사이트AI Stock Insight
C

크레오에스지

040350KOSDAQ컴퓨터 프로그래밍, 시스템 통합 및 관리업

42.0 / 100

Reference Date: 2026-04-13

Financial Score8.5 / 40
News Sentiment15.5 / 25
Momentum6.0 / 20
Disclosure12.0 / 15
AI Analysis: the high debt ratio poses financial risk, ROE is below the industry average. Slightly up 2.5% over the past month, and news sentiment is positive.

Company InformationBased on 2025 Annual Report

Business Overview

Creo SG operates in three main business segments: financial IT solutions, biotech vaccine development, and real estate operations. The solution segment provides core banking systems to banks and non-banks, while the biotech segment focuses on developing vaccines for AIDS, COVID-19, and superbugs, though it currently generates no revenue. The real estate segment manages properties through a subsidiary.

Number of Employees

48people

Average Salary

57.6M KRW

Score Calculation Basis

Detailed Financial Score

PER
—Industry Average 10.404.0Point
PBR
1.43Industry Average 1.062.5Point

Higher than industry avg (caution)

ROE
-17.52Industry Average 6.730.0Point

Well below industry avg

Debt Ratio
69.35Industry Average 11.310.0Point

6.1x industry avg (risky)

Trend 2023~20252.0 / 10 points
Revenue Growth Rate
2.0 / 3

Avg ▲8.4% (2-year basis)

Operating Profit Growth Rate
0.0 / 3

Avg ▼32.4% (2-year basis)

ROE Trend
0.0 / 4

Avg ROE -30.1% (improving, 3yr)

Detailed News Sentiment

5 totalPositive 3Neutral 0Negative 0Average Sentiment Score 70

Detailed Momentum

52-week position1.0Point

Near 52w low (14%, downtrend)

Current 693Won52-week high 1,53352-week low 556
1-month return4.0Point

1m +2.51% (slight rise)

Volume trend1.0Point

Volume dry-up

Detailed Disclosure

12 totalPositive 1Neutral 11Negative 0
  • Neutral금전대여결정2026-04-10
  • Neutral주권매매거래정지 (주식의 병합, 분할 등 전자등록 변경, 말소)2026-04-09
  • Neutral사외이사의선임ㆍ해임또는중도퇴임에관한신고2026-03-31
  • Neutral정기주주총회결과2026-03-31
  • Positive단일판매ㆍ공급계약체결2026-03-25